Cargando…
A 65-Year-Old Male with Primary Central Nervous System Diffuse Large B-Cell Lymphoma on Nivolumab with Oral Mucositis and Targetoid Plaques
BACKGROUND/AIMS: The development of programmed cell death-1 (PD-1) inhibitors has greatly improved patient outcomes in the treatment of a variety of advanced malignancies. These novel immunotherapies are not without adverse effects, the most common of which are dermatologic. METHODS: We report our e...
Autores principales: | Cao, Severine, Rohani, Pooyan, Nazarian, Rosalynn M., Kroshinsky, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803687/ https://www.ncbi.nlm.nih.gov/pubmed/29456996 http://dx.doi.org/10.1159/000481309 |
Ejemplares similares
-
A 23-Year-Old Man with Hyper-IgM Syndrome Presenting with Asymptomatic Violaceous Facial Plaques
por: Barrios, Mirelys, et al.
Publicado: (2020) -
A Case of Nivolumab-Induced Cutaneous Toxicity with Multiple Morphologies
por: Nguyen, Emily D., et al.
Publicado: (2020) -
A Case of Fever and Erythema Nodosum-Like Lesions Leading to a New Diagnosis of Gamma-Delta T-Cell Lymphoma Complicated by Hemophagocytic Lymphohistiocytosis
por: Murphy, William S., et al.
Publicado: (2020) -
A 67-Year-Old Male with Diffuse Purpuric Vesicles and Bullae
por: Yu, Zizi, et al.
Publicado: (2020) -
A 78-Year-Old Female with a Diffuse Pruritic Rash and Palmoplantar Desquamation
por: Molina, Gabriel E., et al.
Publicado: (2020)